Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AFYA Stock Forecast 2026-2027
$14.44
Current Price
$1.32B
Market Cap
Buy 1
Hold 5
Sell 3
Wall St Analyst Ratings
Distance to AFYA Price Targets
+44.5%
To High Target of $20.86
+11.8%
To Median Target of $16.14
-0.1%
To Low Target of $14.42
AFYA Price Momentum
+0.3%
1 Week Change
+3.7%
1 Month Change
-17.7%
1 Year Change
-6.3%
Year-to-Date Change
-22.1%
From 52W High of $18.53
+11.1%
From 52W Low of $13.00
📊 TOP ANALYST CALLS
Did AFYA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Afya is one of their latest high-conviction picks.
Latest AFYA Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, AFYA has a neutral consensus with a median price target of $16.14 (ranging from $14.42 to $20.86). The overall analyst rating is Hold (4.9/10). Currently trading at $14.44, the median forecast implies a 11.8% upside. This outlook is supported by 1 Buy, 5 Hold, and 3 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AFYA Analyst Ratings
1
Buy
5
Hold
3
Sell
AFYA Price Target Range
Low
$14.42
Average
$16.14
High
$20.86
Current: $14.44
Latest AFYA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AFYA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 30, 2026 | JP Morgan | Marcelo Santos | Neutral | Maintains | $21.50 |
| Feb 24, 2026 | B of A Securities | Neutral | Downgrade | $N/A | |
| Feb 13, 2026 | Morgan Stanley | Underweight | Downgrade | $N/A | |
| Jan 16, 2026 | UBS | Neutral | Downgrade | $N/A | |
| Jan 8, 2026 | UBS | Buy | Maintains | $N/A | |
| Jan 7, 2026 | JP Morgan | Neutral | Downgrade | $N/A | |
| Sep 8, 2025 | UBS | Buy | Upgrade | $N/A | |
| Sep 8, 2025 | JP Morgan | Overweight | Upgrade | $N/A | |
| Jul 29, 2025 | Citigroup | Neutral | Upgrade | $N/A | |
| Jun 12, 2025 | UBS | Neutral | Maintains | $N/A | |
| Mar 11, 2025 | Morgan Stanley | Underweight | Downgrade | $N/A | |
| Jan 31, 2025 | Citigroup | Sell | Downgrade | $N/A | |
| Jan 17, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Dec 3, 2024 | Goldman Sachs | Sell | Initiates | $N/A | |
| Aug 30, 2024 | UBS | Neutral | Initiates | $N/A | |
| Jun 21, 2024 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Jan 22, 2024 | Morgan Stanley | Equal-Weight | Downgrade | $N/A | |
| Nov 27, 2023 | JP Morgan | Neutral | Downgrade | $N/A | |
| Oct 13, 2023 | Morgan Stanley | Overweight | Upgrade | $N/A | |
| Nov 22, 2022 | Credit Suisse | Outperform | Maintains | $N/A |
Afya Ltd. (AFYA) Competitors
The following stocks are similar to Afya based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Afya Ltd. (AFYA) Financial Data
Afya Ltd. has a market capitalization of $1.32B with a P/E ratio of 8.8x. The company generates $728.53M in trailing twelve-month revenue with a 20.1% profit margin.
Revenue growth is +8.2% quarter-over-quarter, while maintaining an operating margin of +38.9% and return on equity of +16.8%.
Valuation Metrics
Market Cap
$1.32B
Enterprise Value
$616.96M
P/E Ratio
8.8x
PEG Ratio
2.7x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+8.2%
Gross Margin
+68.9%
Operating Margin
+38.9%
Net Margin
+20.1%
EPS Growth
+2.0%
Financial Health
Cash/Price Ratio
+103.7%
Current Ratio
1.8x
Debt/Equity
66.9x
ROE
+16.8%
ROA
+8.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Afya Ltd. (AFYA) Business Model
About Afya Ltd.
What They Do
Provides medical education and practice solutions.
Business Model
The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It generates revenue by offering undergraduate medical courses, residency preparatory courses, and subscription-based digital tools for healthcare professionals, creating a comprehensive ecosystem that supports physicians throughout their careers.
Additional Information
Afya Ltd. is headquartered in Belo Horizonte, Brazil, and plays a significant role in expanding medical education and professional development in the healthcare sector. Its diverse portfolio includes programs in various fields beyond medicine, catering to a wide range of students and institutions.
Company Information
Sector
Consumer Defensive
Industry
Education & Training Services
Employees
9,395
CEO
Country
Brazil
IPO Year
2019
Website
www.afya.com.brAfya Ltd. (AFYA) Latest News & Analysis
Latest News
Quick Summary
Afya Participações S.A. will hold its Annual General Meeting on June 22, 2026, at 10:00 a.m. BRT, both in-person and virtually. Access online via provided link.
Why It Matters
The AGM announcement indicates potential strategic decisions affecting Afya Participações S.A.'s future, which could impact stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Should Value Investors Buy Afya (AFYA) Stock?
12 days ago
Quick Summary
Zacks utilizes the Zacks Rank system, focusing on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends.
Why It Matters
The Zacks Rank system highlights earnings estimates and revisions, indicating stocks with potential growth. Trends in value, growth, and momentum signal strong investment opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know
15 days ago
Quick Summary
Wall Street analysts suggest a 25.6% potential upside for Afya (AFYA), supported by positive earnings estimate revisions.
Why It Matters
The 25.6% upside in Afya's price targets signals potential gains, and positive earnings revisions suggest improving fundamentals, which may attract investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Investors are evaluating Afya (AFYA) and American Public Education (APEI) for potential value opportunities in the education sector.
Why It Matters
The comparison between Afya and American Public Education highlights potential investment opportunities, guiding investors in identifying which stock may offer better returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks emphasizes its Rank system based on earnings estimates and revisions to identify top stocks, while also monitoring value, growth, and momentum trends for investment opportunities.
Why It Matters
The Zacks Rank system highlights stocks with favorable earnings estimates, signaling potential growth. Trends in value, growth, and momentum can guide investment decisions for better returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Afya Limited (AFYA) held its Q1 2026 earnings call, providing insights into financial performance and business updates. Detailed earnings figures and strategic initiatives were discussed.
Why It Matters
Afya Limited's Q1 2026 earnings call reveals financial health and growth potential, impacting stock valuation and investor sentiment. Key insights may influence trading strategies.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About AFYA Stock
What is Afya Ltd.'s (AFYA) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Afya Ltd. (AFYA) has a median price target of $16.14. The highest price target is $20.86 and the lowest is $14.42.
Is AFYA stock a good investment in 2026?
According to current analyst ratings, AFYA has 1 Buy ratings, 5 Hold ratings, and 3 Sell ratings. The stock is currently trading at $14.44. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AFYA stock?
Wall Street analysts predict AFYA stock could reach $16.14 in the next 12 months. This represents a 11.8% increase from the current price of $14.44. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Afya Ltd.'s business model?
The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It generates revenue by offering undergraduate medical courses, residency preparatory courses, and subscription-based digital tools for healthcare professionals, creating a comprehensive ecosystem that supports physicians throughout their careers.
What is the highest forecasted price for AFYA Afya Ltd.?
The highest price target for AFYA is $20.86 from at , which represents a 44.5% increase from the current price of $14.44.
What is the lowest forecasted price for AFYA Afya Ltd.?
The lowest price target for AFYA is $14.42 from at , which represents a -0.1% decrease from the current price of $14.44.
What is the overall AFYA consensus from analysts for Afya Ltd.?
The overall analyst consensus for AFYA is neutral. Out of 2 Wall Street analysts, 1 rate it as Buy, 5 as Hold, and 3 as Sell, with a median price target of $16.14.
How accurate are AFYA stock price projections?
Stock price projections, including those for Afya Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 9:27 AM UTC